Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 12.36 USD 4.48% Market Closed
Market Cap: 135.8m USD

EV/EBITDA
Enterprise Value to EBITDA

-4.7
Current
1.3
Median
10.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-4.7
=
Enterprise Value
-37.7m USD
/
EBITDA
8m USD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
US
Medifast Inc
NYSE:MED
Average EV/EBITDA: 43.2
Negative Multiple: -4.7
N/A N/A
FR
L'Oreal SA
PAR:OR
18.7
5%
3.7
UK
Unilever PLC
LSE:ULVR
201.5
2%
100.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
35.4
8%
4.4
UK
HALEON PLC
LSE:HLN
13.6
4%
3.4
US
Estee Lauder Companies Inc
NYSE:EL
20.5
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.5
-1%
N/A
JP
Kao Corp
TSE:4452
11.4
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
40.2
13%
3.1
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -1 825.9 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
36.4
11%
3.3

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
hidden
2-Years Forward
EV/EBITDA
hidden
3-Years Forward
EV/EBITDA
N/A